News from mimedx, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 27, 2015, 10:11 ET

MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Aug 26, 2015, 09:40 ET

MiMedx Announces Publication Of Latest Scientific Study Demonstrating The Ability Of Its Allografts To Regulate Diabetic Stem Cells

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Aug 21, 2015, 08:30 ET

MiMedx Patent Infringement Lawsuits Receive Favorable Rulings From Patent Trial And Review Board

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Aug 06, 2015, 12:00 ET

MiMedx Updates Second Quarter Information

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Aug 03, 2015, 14:00 ET

MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jul 30, 2015, 07:30 ET

MiMedx Announces Record Results for Second Quarter of 2015

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jul 15, 2015, 16:00 ET

Scientific Study Demonstrates That MiMedx Allografts Stimulate Cellular Proliferation And Migration In A Variety Of Adult Stem Cells

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jul 08, 2015, 14:25 ET

MiMedx Announces Release Date for 2015 Second Quarter Results

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Jun 29, 2015, 13:18 ET

EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

May 27, 2015, 09:00 ET

MiMedx To Present At The Jefferies 2015 Global Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

May 19, 2015, 10:39 ET

MiMedx To Present At The 12th Annual Craig-Hallum Institutional Investor Conference

 MiMedx Group, Inc.  (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected...

May 13, 2015, 14:53 ET

MiMedx Announces Publication On CollaFix™, The Company's Next Technology Platform To Be Commercialized

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

May 08, 2015, 08:00 ET

MiMedx Receives 2015 Innovative Technology Award from Novation

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 29, 2015, 10:20 ET

Comparative Effectiveness Study Exhibiting Superior Outcomes Of MiMedx EpiFix® Receives Award At SAWC Conference

MiMedx Group, Inc. (NASDAQ: MDXG) announced today that one oral abstract and four poster abstracts showing the Company's EpiFix® allografts to...

Apr 27, 2015, 19:46 ET

MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 23, 2015, 09:00 ET

MiMedx To Present At The 40th Annual Deutsche Bank Securities Healthcare Conference

MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 13, 2015, 16:30 ET

MiMedx Announces Expansion Of Health Plan Coverage

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 13, 2015, 16:15 ET

MiMedx Reports Record First Quarter 2015 Revenue of $40.8 Million

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 03, 2015, 09:34 ET

MiMedx Group, Inc. Announces Release Date for 2015 First Quarter Results

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...

Apr 01, 2015, 11:36 ET

MiMedx To Present At The 14th Annual Needham Healthcare Conference

 MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to...